Wu; Dechun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Dechun.The latest application filed is for "bispecific t-cell engager with cleavable cytokines for targeted immunotherapy".

Company Profile

0.7.14

Wu; Dechun - Shenzhen CN
Wu; Dechun - Bridgewater NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific T-cell Engager With Cleavable Cytokines For Targeted Immunotherapy App 20220233711 - Liu; Shumin ; et al.	2022-07-28
Accelerated hydrolysis system Grant 11,235,332 - Han , et al. February 1, 2	2022-02-01
Long Acting Multi-Specific Molecules And Related Methods App 20210338832 - Liu; Shu-min ; et al.	2021-11-04
Long acting multi-specific molecules and related methods Grant 11,065,342 - Liu , et al. July 20, 2	2021-07-20
Accelerated Hydrolysis System App 20190381508 - Han; Yuxin ; et al.	2019-12-19
Long Acting Multi-Specific Molecules And Related Methods App 20190298844 - Liu; Shu-min ; et al.	2019-10-03
Polymeric Conjugates Of Aromatic Amine Containing Compounds Including Releasable Urea Linker App 20120289571 - Zhao; Hong ; et al.	2012-11-15
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers Grant 8,299,089 - Zhao , et al. October 30, 2	2012-10-30
Methods of preparing activated polymers having alpha nitrogen groups Grant 8,133,707 - Zhao , et al. March 13, 2	2012-03-13
Branched Cationic Lipids For Nucleic Acids Delivery System App 20110305769 - Zhao; Hong ; et al.	2011-12-15
Releasable Polymeric Lipids For Nucleic Acids Delivery System App 20110305770 - Zhao; Hong ; et al.	2011-12-15
Releasable Cationic Lipids For Nucleic Acids Delivery Systems App 20110229581 - Zhao; Hong ; et al.	2011-09-22
Releasable Fusogenic Lipids For Nucleic Acids Delivery Systems App 20110223257 - Zhao; Hong ; et al.	2011-09-15
Multi-arm Polymeric Conjugates Of 7-ethyl-10-hydroxycamptothecin For Treatment Of Breast, Colorectal, Pancreatic, Ovarian And Lung Cancers App 20100204261 - ZHAO; Hong ; et al.	2010-08-12
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers Grant 7,723,351 - Zhao , et al. May 25, 2	2010-05-25
Multi-arm Polymeric Conjugates Of 7-ethyl-10-hydroxycamptothecin For Treatment Of Breast, Colorectal, Pancreatic, Ovarian And Lung Cancers App 20090074706 - ZHAO; Hong ; et al.	2009-03-19
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers Grant 7,462,627 - Zhao , et al. December 9, 2	2008-12-09
Process for the preparation of polymer conjugates Grant 7,365,127 - Wu , et al. April 29, 2	2008-04-29
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers App 20070197575 - Zhao; Hong ; et al.	2007-08-23
Methods of preparing activated polymers having alpha nitrogen groups App 20070166808 - Zhao; Hong ; et al.	2007-07-19
Process for the preparation of polymer conjugates App 20060178474 - Wu; Dechun ; et al.	2006-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.